Literature DB >> 9131586

The genetic defect causing Huntington's disease: repeated in other contexts?

J F Gusella1, F Persichetti, M E MacDonald.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9131586      PMCID： PMC2230063     

Source DB:  PubMed          Journal:  Mol Med        ISSN： 1076-1551            Impact factor:   6.354


× No keyword cloud information.
  88 in total

1.  Discrepancy resolved.

Authors:  R H Myers; M E MacDonald; J F Gusella
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

2.  Mutation size and age at onset in Huntington's disease.

Authors:  D Craufurd; A Dodge
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

3.  Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset.

Authors:  L P Ranum; M Y Chung; S Banfi; A Bryer; L J Schut; R Ramesar; L A Duvick; A McCall; S H Subramony; L Goldfarb
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

4.  Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat.

Authors:  Christine M Ambrose; Mabel P Duyao; Glenn Barnes; Gillian P Bates; Carol S Lin; Jayalakshmi Srinidhi; Sarah Baxendale; Holger Hummerich; Hans Lehrach; Michael Altherr; John Wasmuth; Alan Buckler; Deanna Church; David Housman; Mary Berks; Gos Micklem; Richard Durbin; Alan Dodge; Andrew Read; James Gusella; Marcy E MacDonald
Journal:  Somat Cell Mol Genet       Date:  1994-01

5.  Mutation analysis in patients with possible but apparently sporadic Huntington's disease.

Authors:  M B Davis; D Bateman; N P Quinn; C D Marsden; A E Harding
Journal:  Lancet       Date:  1994-09-10       Impact factor: 79.321

6.  A study of the Huntington's disease associated trinucleotide repeat in the Scottish population.

Authors:  L H Barron; J P Warner; M Porteous; S Holloway; S Simpson; R Davidson; D J Brock
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

7.  Molecular analysis of late onset Huntington's disease.

Authors:  B Kremer; F Squitieri; H Telenius; S E Andrew; J Theilmann; N Spence; Y P Goldberg; M R Hayden
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

8.  Presymptomatic analysis of spinocerebellar ataxia type 1 (SCA1) via the expansion of the SCA1 CAG-repeat in a large pedigree displaying anticipation and parental male bias.

Authors:  T Matilla; V Volpini; D Genís; J Rosell; J Corral; A Dávalos; A Molins; X Estivill
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

9.  Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset.

Authors:  Y Trottier; V Biancalana; J L Mandel
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

10.  Mouse Huntington's disease gene homolog (Hdh).

Authors:  G T Barnes; M P Duyao; C M Ambrose; S McNeil; F Persichetti; J Srinidhi; J F Gusella; M E MacDonald
Journal:  Somat Cell Mol Genet       Date:  1994-03
View more
  8 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity.

Authors:  Peter W Faber; Cindy Voisine; Daphne C King; Emily A Bates; Anne C Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

3.  Analysis of the mouse transcriptome for genes involved in the function of the nervous system.

Authors:  Stefano Gustincich; Serge Batalov; Kirk W Beisel; Hidemasa Bono; Piero Carninci; Colin F Fletcher; Sean Grimmond; Nobutaka Hirokawa; Erich D Jarvis; Tim Jegla; Yuka Kawasawa; Julianna LeMieux; Harukata Miki; Elio Raviola; Rohan D Teasdale; Naoko Tominaga; Ken Yagi; Andreas Zimmer; Yoshihide Hayashizaki; Yasushi Okazaki
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

Review 4.  Molecular pathogenesis of spinocerebellar ataxia type 6.

Authors:  Holly B Kordasiewicz; Christopher M Gomez
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

5.  Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

Authors:  P Klivenyi; O A Andreassen; R J Ferrante; A Dedeoglu; G Mueller; E Lancelot; M Bogdanov; J K Andersen; D Jiang; M F Beal
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

6.  Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins.

Authors:  S Krobitsch; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  Genetic studies in Alzheimer's disease.

Authors:  Ya-Ping Tang; Elliot S Gershon
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

8.  Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset.

Authors:  Eliana Marisa Ramos; Jeanne C Latourelle; Tammy Gillis; Jayalakshmi S Mysore; Ferdinando Squitieri; Alba Di Pardo; Stefano Di Donato; Cinzia Gellera; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Ruth K Abramson; Karen Marder; James F Gusella; Jong-Min Lee; Isabel Alonso; Jorge Sequeiros; Richard H Myers; Marcy E Macdonald
Journal:  Neurogenetics       Date:  2013-05-04       Impact factor: 2.660
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.